Brief: Alligator Bioscience CMO Leaves
24/03/2025 06:36
March 24 (Reuters) - Alligator Bioscience AB ATORX.ST: SAID ON FRIDAY SUMEET AMBARKHANE MD, CHIEF MEDICAL OFFICER, WILL BE LEAVING ALLIGATOR BY END OF MARCH 2025 TOM MOORE WILL ASSUME ROLE AS CHIEF MEDICAL OFFICER FROM BEGINNING OF APRIL Source text for Workspace: nMFN9LMSFC Further company coverage: ATORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln